Table 1. Association between expression of PBK/TOPK and clinical characteristics in 185 NPC patients.
| Characteristics | No. | PBK/TOPK expression | P value (Chi-square test) | |
|---|---|---|---|---|
| Low | High | |||
| Gender | ||||
| Male | 142 | 73 | 69 | 0.574 |
| Female | 43 | 20 | 23 | |
| Age | ||||
| <45 | 96 | 48 | 48 | 0.939 |
| ≥45 | 89 | 45 | 44 | |
| T stage | ||||
| T1-2 | 56 | 35 | 21 | 0.028 |
| T3-4 | 129 | 58 | 71 | |
| N stage | ||||
| N0-1 | 104 | 57 | 47 | 0.162 |
| N2-3 | 81 | 36 | 45 | |
| M stage | ||||
| M0 | 169 | 89 | 80 | 0.838 |
| M1 | 16 | 8 | 8 | |
| Clinical stage | ||||
| I-II | 22 | 14 | 8 | 0.182 |
| III-IV | 163 | 79 | 84 | |
| Death | ||||
| Yes | 49 | 17 | 32 | 0.011 |
| No | 136 | 76 | 60 | |
| Disease progression | ||||
| Yes | 24 | 6 | 18 | 0.008 |
| No | 161 | 87 | 74 | |
| WHO histological classification Type 2 | ||||
| Differentiated | 15 | 8 | 7 | 0.942 |
| Undifferentiated | 169 | 89 | 81 | |
Abbreviations: WHO, World Health Organization